We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Head-to-head evidence comparison — which supplement is right for you?
CoQ10 wins 1 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Likely helps
16 of 20 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
9 of 11 studies with measurable effects showed benefit.
Top outcomes
100-300mg daily
With fatty meal
Ubiquinol (reduced form)
40-80mg isoflavones daily
Divided doses with meals, Consistent daily timing
Standardized soy isoflavone extract
2-4 weeks
4-8 weeks
8-12 weeks
4-12 weeks
6-12 months
8-12 weeks
Initial use
Efficacy and Safety of Coenzyme Q10 Supplementation in the Treatment of Polycystic Ovary Syndrome: a Systematic Review and Meta-analysis
Reproductive sciences (Thousand Oaks, Calif.) (2023) · Meta analysis · n=1021
Only one RCT reported adverse events, and they found that patients had no adverse effects or symptoms following supplementation.
Coenzyme Q10 for heart failure
The Cochrane database of systematic reviews (2021) · Meta analysis · n=1573
Coenzyme Q10 probably reduces the risk of all-cause mortality more than control (RR 0.58, 95% CI 0.35 to 0.95; 1 study, 420 participants; number needed to treat for an additional beneficial outcome (NNTB) 13.3; moderate-quality evidence).
Antioxidants for female subfertility
The Cochrane database of systematic reviews (2017) · Meta analysis · n=6510
This suggests that among subfertile women with an expected clinical pregnancy rate of 22%, the rate among women using antioxidants would be between 27% and 33%.
Soy isoflavones prevent bone resorption and loss, a systematic review and meta-analysis of randomized controlled trials
Critical reviews in food science and nutrition (2020) · Meta analysis · n=5313
Soy isoflavones prevent osteoporosis-related bone loss in any weight status or treatment duration.
Effect of Soy Isoflavones on Measures of Estrogenicity: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Advances in nutrition (Bethesda, Md.) (2025) · Meta analysis · n=3285
Addressing public health concerns may promote soy foods as high-quality plant protein sources with low environmental impact and cost, particularly benefiting postmenopausal women and aligning with sustainable dietary patterns and guidelines.
Effects of soy isoflavones on menopausal symptoms in perimenopausal women: a systematic review and meta-analysis
PeerJ (2025) · Meta analysis · n=533
In October 2024, we screened 2,099 articles, of which 12 were eligible for meta-analysis, and found that soy isoflavones were effective for treating menopausal symptoms (seven studies, 533 participants, Hedges' g = -0.25, 95% CI [-0.42 to -0.08], p = 0.00).
Based on heart failure meta-analysis (n=1573) showing mortality reduction. Effectiveness conservative due to single primary study (n=420). Take with food to reduce GI upset. Ubiquinol forms may have better absorption.
Meta-analysis of 533 participants showed effectiveness for menopausal symptoms. Effect size appears modest and heterogeneity was noted across studies. Individual response varies significantly.
AI-estimated from published studies. Interpret as directional guidance.
CoQ10 has a higher evidence score (9/10 vs 9/10) and wins in 1 of 3 categories.
For fertility support, CoQ10 has a higher relevance score (90 vs 70).
No known interactions between CoQ10 and Soy Isoflavones have been documented in our database. However, always consult a healthcare provider before combining supplements.